Wednesday, April 27, 2022

FDA MedWatch- Potential Risk of Airway Obstruction When Using Certain Electromyogram Endotracheal Tubes: Letter to Health Care Providers

The FDA is evaluating the potential risk of airway obstruction when using silicone-based electromyogram endotracheal tubes

This email was sent to using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment